Supervised consumption bill AB 362 stalls; Critical need for overdose prevention services continues
California Assembly Bill (AB) 362, which would have allowed San Francisco and Oakland to authorize pilot overdose prevention programs, will not move forward this legislative session.
We are seeing with our own eyes the COVID-19 and HIV disparities that affect Latinx communities, so we must be creative with our services, said Jorge Zepeda from Latino Programs.
We cannot let racist tropes come to define Kamala Harris
With Senator Kamala Harris announced as the Democratic party's vice-presidential candidate, this is a moment when Black people can shape conversations so that she is not limited to the racist perceptions of the media.
Harm reduction “stations” prevent overdose in hotels during COVID-19
Our Syringe Access Services team is ensuring that about 2,000 San Franciscans housed in hotel rooms during COVID-19 have easy access to harm reduction and overdose prevention supplies.
Talking to a loved one about their meth use: Advice from a substance use counselor
Offer your support, set boundaries, educate yourself about the realities of meth use, and avoid demanding that they stop using, said Jeremy Prillwitz, MA, LAADC, a counselor with The Stonewall Project.
“Tremendously exciting” news of cabotegravir long-acting injectable for PrEP shared at AIDS 2020
Final results of the HPTN 083 study show that for men who have sex with men and transgender women, a cabotegravir injection provided highly effective HIV prevention when given once every two months.
SFAF urges California Legislature to pass AB 362 as support for safe consumption spaces grows
As support for safe consumption spaces in San Francisco grows, we urge the California Legislature to pass AB 362, which would allow San Francisco and Oakland to pilot safe consumption spaces.
High effectiveness and adherence to PrEP 2-1-1 in large San Francisco AIDS Foundation study
At AIDS 2020, San Francisco AIDS Foundation presented positive findings from one of the largest pre-exposure prophylaxis (PrEP) 2-1-1 adherence and effectiveness studies to date.
AIDS 2020: Our innovations in HIV, PrEP, sexual health & harm reduction
San Francisco AIDS Foundation shared information about the incredible impact of our programs, services and research during AIDS 2020. See what we shared at the conference.
How to afford PrEP and HIV meds if you lose health insurance
There are a variety of free programs that can help people afford medications and care even if they don’t have insurance. Read on for advice from Reina Hernandez, a PrEP benefits and HIV linkage manager from San Francisco
New research finds that 1 in 13 people experienced viral rebound after becoming undetectable, with disparities related to race, housing status, age, and more.
